Director Bryan Roberts resigns from 10x Genomics board; Popovits joins Audit Committee

10x Genomics, Inc.

Bryan E. Roberts resigned from the Board and its Audit and Compensation committees effective July 18, 2023.
Resignation due solely to professional time commitments; no disagreement with management or operations.
Kimberly J. Popovits appointed to the Audit Committee effective July 19, 2023.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bryan E. Roberts

Director

TXG · 10x Genomics, Inc.

Effective: 2023-07-18
Filed: July 20, 2023, 7:59 PM ET

On July 18, 2023, Bryan E. Roberts informed 10x Genomics, Inc. (the "Company") of his decision to resign as a member of the Board of Directors (the "Board") of the Company, the Audit Committee of the Board and the Compensation Committee of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Bryan E. Roberts resigned as Director at 10x Genomics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On July 18, 2023, Bryan E. Roberts informed 10x Genomics, Inc. (the "Company") of his decision to resign as a member of the Board of Directors (the "Board") of the Company, the Audit Committee of the Board and the Compensation Committee of the Board, effective immediately.

View on SEC.gov

10x Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001770787-23-000038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.